Dr. Vince Clinical Research
Ben Abrams serves as the Director of Business Development at Dr. Vince Clinical Research since March 2024, overseeing operations at a 90-bed clinical pharmacology unit that specializes in First-in-Human/Phase 1 trials. Prior to this role, Ben held significant positions including Director of Business Development for QPS Holdings, LLC from October 2015 to February 2024, managing growth and customer relationships in Early Phase Clinical services. Ben's earlier experience includes positions as Associate Director at Quintiles and Director of Business Development at ICON plc and MEDTOX Laboratories. Ben began a career in the pharmaceutical industry at Schering-Plough Pharmaceuticals as a Professional Sales Representative and has a Bachelor of Arts degree in Business, Management, Marketing, and Related Support Services from Saint John's University.
Dr. Vince Clinical Research
Dr. Vince Clinical Research (DVCR) is a full-service contract research organization (CRO) specializing in early phase trials in both healthy normal volunteers and patient populations across a wide range of trial designs and multiple therapeutic areas such as neuroscience, psychiatry, substance abuse, pain, cardiometabolic disorders, infectious diseases and others. CRO services include project management, data management, biostatistics, monitoring, PK/PD analysis, medical writing as well as site feasibility and management for multi-center trials. Additionally, DVCR operates one of the most innovative and technologically advanced clinical pharmacology units in the world with over 90 beds for overnight confinement, a cGMP compliant pharmacy as well as luxurious amenities to support diverse study participant recruitment and retention. By leveraging technology and one of the country’s most experienced leadership teams in early clinical development, DVCR provides Smarter Faster Data® to their biopharmaceutical clients.